Universitätsklinikum Ulm

Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma (2017) Einsele H, Knop S, Vogel M, Mueller J, Kropff M, Metzner B, Langer C, et al. Journal article Prognostic factors for tumor recurrence in patients with clinical stage I seminoma undergoing surveillance-A systematic review (2017) Zengerling F, Kunath F, Jensen K, Ruf C, Schmidt S, Spek A Journal article Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology (2017) Ripperger T, Bielack SS, Borkhardt A, Brecht IB, Burkhardt B, Calaminus G, Debatin KM, et al. Journal article Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial (2017) Einsele H, Engelhardt M, Tapprich C, Mueller J, Liebisch P, Langer C, Kropff M, et al. Journal article Arterial Hyper- and Hypotension associated with psychiatric medications: a risk assessment based on the summaries of product characteristics (SmPCs) (2017) Freudenmann RW, Freudenmann N, Zurowski B, Schönfeldt-Lecuona C, Maier L, Schmieder R, Lange-Asschenfeldt C, Gahr M Journal article IMP3 and p16 expression in squamous cell carcinoma of the head and neck: A comparative immunohistochemical analysis (2017) Riener MO, Hoegel J, Iro H, Hartmann A, Agaimy A Journal article Complement-induced activation of the cardiac NLRP3 inflammasome in sepsis (2016) Kalbitz M, Fattahi F, Grailer JJ, Jajou L, Malan EA, Zetoune FS, Huber-Lang M, et al. Journal article Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: A study of the AML study group (2016) Theis FJ, Corbacioglu A, Gaidzik VI, Paschka P, Weber D, Bullinger L, Heuser M, et al. Journal article Complement destabilizes cardiomyocyte function in vivo after polymicrobial sepsis and in vitro (2016) Kalbitz M, Fattahi F, Herron TJ, Grailer JJ, Jajou L, Lu H, Huber-Lang M, et al. Journal article Six Versus Twelve Months Clopidogrel Therapy after Drug-Eluting Stenting in Patients with Acute Coronary Syndrome: An ISAR-SAFE Study Subgroup Analysis (2016) Lohaus R, Michel J, Mayer K, Lahmann AL, Byrne RA, Wolk A, Ten Berg JM, et al. Journal article